Literature DB >> 28383004

Promising cancer drugs may speed tumours in some patients.

Heidi Ledford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28383004     DOI： 10.1038/nature.2017.21755

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy.

Authors:  Jonathan S Kurman; Septimiu D Murgu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

2.  Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.

Authors:  Xuerong Sun; Benyan Shi; Huiling Zheng; Ling Min; Jie Yang; Xiaoyi Li; Xiaoxin Liao; Weixing Huang; Mingmeng Zhang; Shun Xu; Zhe Zhu; Hongjing Cui; Xinguang Liu
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

3.  Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case series.

Authors:  Masaki Kanazu; Ryuya Edahiro; Hiroyuki Krebe; Kohei Nishida; Mikako Ishijima; Takeshi Uenami; Yuki Akazawa; Yukihiro Yano; Toshihiko Yamaguchi; Masahide Mori
Journal:  Thorac Cancer       Date:  2018-10-17       Impact factor: 3.500

Review 4.  Emerging therapies for non-small cell lung cancer.

Authors:  Chao Zhang; Natasha B Leighl; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Hematol Oncol       Date:  2019-04-25       Impact factor: 17.388

5.  Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis.

Authors:  Deirdre M H J Ten Berge; Daniel P Hurkmans; Ilse den Besten; Jeroen S Kloover; Ron H J Mathijssen; Reno Debets; Egbert F Smit; Joachim G J V Aerts
Journal:  ERJ Open Res       Date:  2019-12-16

6.  Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study.

Authors:  Valentina Masciale; Giulia Grisendi; Federico Banchelli; Roberto D'Amico; Antonino Maiorana; Pamela Sighinolfi; Alessandro Stefani; Uliano Morandi; Massimo Dominici; Beatrice Aramini
Journal:  Front Oncol       Date:  2019-12-18       Impact factor: 6.244

7.  Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors.

Authors:  Marjorie Faure; Philippe Rochigneux; Daniel Olive; Sébastien Taix; Isabelle Brenot-Rossi; Marine Gilabert
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.